middle.news
Dimerix Opens First Japan Site, Secures AU$4.3M Milestone for Kidney Drug
1:18am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Dimerix Opens First Japan Site, Secures AU$4.3M Milestone for Kidney Drug
1:18am on Monday 2nd of June, 2025 AEST
Key Points
First clinical trial site in Japan for ACTION3 Phase 3 study now recruiting
Milestone payment of ¥400 million (~AU$4.3 million) triggered from FUSO Pharmaceutical
FUSO to manage clinical development and regulatory submissions in Japan
Dimerix continues global trial execution and licensing efforts outside Japan
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Dimerix (ASX:DXB)
OPEN ARTICLE